Abiopharma

🔍 Khan Nazar M. (Director)

Company: TERAWULF INC. (WULF)

Report Date: 2026-04-14

Detailed Transactions and Holdings:

• Acquired 817,635 shares of Common stock, $0.001 par value per share (Direct)
  Date: 2026-04-14 | Code: M | equity_swap_involved: 0 | shares_owned_after: 818,135.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 444,992 shares of Common stock, $0.001 par value per share (Direct)
  Date: 2026-04-14 | Code: D | equity_swap_involved: 0 | shares_owned_after: 373,143.00 | transaction_form_type: 4 | Footnotes: F2
• Holds 0 shares of Common stock, $0.001 par value per share (Direct)
  Date: 2026-04-14 | Code: H | nature_of_ownership: By The Nazar M. Khan Revocable Trust | shares_owned_after: 14,323,523.00 | Footnotes: F3
• Holds 0 shares of Common stock, $0.001 par value per share (Direct)
  Date: 2026-04-14 | Code: H | nature_of_ownership: By Lake Harriet Holdings LLC | shares_owned_after: 7,269,019.00 | Footnotes: F4
• Holds 0 shares of Common stock, $0.001 par value per share (Direct)
  Date: 2026-04-14 | Code: H | nature_of_ownership: By Yaqeen I Trust | shares_owned_after: 414,939.00 | Footnotes: F5
• Holds 0 shares of Common stock, $0.001 par value per share (Direct)
  Date: 2026-04-14 | Code: H | nature_of_ownership: By Various Trusts | shares_owned_after: 4,019,787.00 | Footnotes: F6
• Sold 817,635 shares of Performance-Based Restricted Stock Units (Derivative)
  Date: 2026-04-14 | Code: M | equity_swap_involved: 0 | shares_owned_after: 2,452,904.00 | transaction_form_type: 4 | Footnotes: F7, F8, F1, F1

Footnotes:

• F1: The performance stock units vested in accordance with their terms upon the achievement of specified performance goals between the grant date and the third anniversary of January 2, 2026, subject to the Reporting Person's continued employment or service with the Issuer through such date.
• F2: The disposition is due to withholding to cover taxes, as a result of the Reporting Person's election of net settlement of performance stock units, which vest in accordance with their terms upon the achievement of specified performance goals between the grant date and the third anniversary of January 2, 2026, subject to the Reporting Person's continued employment or service with the Issuer through each such date.
• F3: By The Nazar M. Khan Revocable Trust ("Khan Revocable Trust"). From April 2025 through January 2026, the Reporting Person contributed an aggregate 14,323, 523 shares of common stock ("Common Stock") to the Khan Revocable Trust for no consideration. The Reporting Person is the sole trustee of the Khan Revocable Trust and may be deemed to have the power to direct the voting and disposition of the Common Stock beneficially owned by the Khan Trust. Accordingly, pursuant to the regulations promulgated under Section 13(d) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), the Reporting Person may be deemed to be a beneficial owner of the shares of Common Stock held for the account of the Khan Revocable Trust.
• F4: By Lake Harriet Holdings, LLC ("Lake Harriet Holdings"). The Khan Revocable Trust is the sole member of Lake Harriet Holdings. The Reporting Person is the sole trustee of the Khan Revocable Trust and may be deemed to have the power to direct the voting and disposition of the Common Stock beneficially owned by the Khan Revocable Trust. Accordingly, pursuant to the regulations promulgated under Section 13(d) of the Exchange Act, the Reporting Person may be deemed to be a beneficial owner of the shares of Common Stock held for the account of the Khan Revocable Trust.
• F5: By Yaqeen I Trust. The Reporting Person may be deemed to beneficially own the Shares held by Yaqeen I Trust. The Reporting Person disclaims beneficial ownership of the Shares except to the extent of his pecuniary interest therein, and the inclusion of the Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Shares for purposes of Section 16 of the Securities Exchange of 1934, as amended, or for any other purpose.
• F6: By various trusts. The Reporting Person may be deemed to beneficially own the Shares held by such trusts. The Reporting Person disclaims beneficial ownership of the Shares except to the extent of his pecuniary interest therein, and the inclusion of the Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Shares for purposes of Section 16 of the Securities Exchange of 1934, as amended, or for any other purpose.
• F7: Each performance stock unit represents a contingent right to receive one share of the Issuer's Common Stock.
• F8: The remaining performance stock units will vest in accordance with their terms upon the achievement of specified performance goals between the grant date and the third anniversary of January 2, 2026, subject to the Reporting Person's continued employment or service with the Issuer through each such date.